Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Omega-3-acid ethyl esters - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for omega-3-acid ethyl esters and what is the scope of omega-3-acid ethyl esters patent protection?

Omega-3-acid ethyl esters
is the generic ingredient in three branded drugs marketed by Par Pharm Inc, Teva Pharms Usa, Amneal Pharms, Smithkline Beecham, Apotex Inc, and Trygg, and is included in six NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for omega-3-acid ethyl esters. Eighteen suppliers are listed for this compound.

Summary for Generic Name: omega-3-acid ethyl esters

Tradenames:3
Patents:1
Applicants:6
NDAs:6
Drug Master File Entries: see list13
Suppliers / Packagers: see list18
Clinical Trials: see list2,172
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:omega-3-acid ethyl esters at DailyMed

Pharmacology for Ingredient: omega-3-acid ethyl esters

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms
OMEGA-3-ACID ETHYL ESTERS
omega-3-acid ethyl esters
CAPSULE;ORAL204940-001Nov 27, 2015ABRXNoNo► Subscribe► Subscribe
Par Pharm Inc
OMEGA-3-ACID ETHYL ESTERS
omega-3-acid ethyl esters
CAPSULE;ORAL091018-001Jun 24, 2014ABRXNoNo► Subscribe► Subscribe
Apotex Inc
OMEGA-3-ACID ETHYL ESTERS
omega-3-acid ethyl esters
CAPSULE;ORAL090973-001Sep 30, 2014ABRXNoNo► Subscribe► Subscribe
Smithkline Beecham
LOVAZA
omega-3-acid ethyl esters
CAPSULE;ORAL021654-001Nov 10, 2004ABRXYesYes► Subscribe► Subscribe
Trygg
OMTRYG
omega-3-acid ethyl esters type a
CAPSULE;ORAL204977-001Apr 23, 2014RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot